WO2007063509A8 - Phosphocreatine complexes - Google Patents

Phosphocreatine complexes

Info

Publication number
WO2007063509A8
WO2007063509A8 PCT/IB2006/054515 IB2006054515W WO2007063509A8 WO 2007063509 A8 WO2007063509 A8 WO 2007063509A8 IB 2006054515 W IB2006054515 W IB 2006054515W WO 2007063509 A8 WO2007063509 A8 WO 2007063509A8
Authority
WO
WIPO (PCT)
Prior art keywords
complexes
phosphocreatine
diseases
novel
fall
Prior art date
Application number
PCT/IB2006/054515
Other languages
French (fr)
Other versions
WO2007063509A2 (en
WO2007063509A3 (en
Inventor
Sergey Vladimirovich Burov
Michael Lensman
Sergey Aleksandrovich Polenov
Pavel Pavlovich Yakutseni
Maurizio Balestrino
Original Assignee
Univ Degli Studi Genova
Sergey Vladimirovich Burov
Michael Lensman
Sergey Aleksandrovich Polenov
Pavel Pavlovich Yakutseni
Maurizio Balestrino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Genova, Sergey Vladimirovich Burov, Michael Lensman, Sergey Aleksandrovich Polenov, Pavel Pavlovich Yakutseni, Maurizio Balestrino filed Critical Univ Degli Studi Genova
Publication of WO2007063509A2 publication Critical patent/WO2007063509A2/en
Publication of WO2007063509A8 publication Critical patent/WO2007063509A8/en
Publication of WO2007063509A3 publication Critical patent/WO2007063509A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/222—Amides of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

The invention relates to novel phosphocreatine complexes useful for the treatment of diseases of the central nervous system, having the following general formula (I): wherein M is a metal, preferably Mg, and An- is an organic or inorganic anion. The pharmaceutically acceptable salts of such complexes also fall within the scope of the invention.
PCT/IB2006/054515 2005-11-30 2006-11-29 Phosphocreatine complexes WO2007063509A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITTO2005A000847 2005-11-30
IT000847A ITTO20050847A1 (en) 2005-11-30 2005-11-30 COMPLEXES OF PHOSPHOCREATIN

Publications (3)

Publication Number Publication Date
WO2007063509A2 WO2007063509A2 (en) 2007-06-07
WO2007063509A8 true WO2007063509A8 (en) 2007-09-07
WO2007063509A3 WO2007063509A3 (en) 2007-10-18

Family

ID=38092648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/054515 WO2007063509A2 (en) 2005-11-30 2006-11-29 Phosphocreatine complexes

Country Status (2)

Country Link
IT (1) ITTO20050847A1 (en)
WO (1) WO2007063509A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140044690A1 (en) * 2012-08-08 2014-02-13 University Of South Florida High-Energy Compounds for Use in Alzheimer's and Other Neurodegenerative Diseases
CN111777636B (en) * 2020-07-09 2023-06-16 山东罗欣药业集团股份有限公司 Preparation method of medicine for myocardial protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR168F (en) * 1966-04-08
NZ524510A (en) * 2000-09-14 2005-08-26 Univ Nebraska Creatine ester pronutrient compounds and formulations
CN1709896A (en) * 2005-07-10 2005-12-21 杨喜鸿 Magnesium salt of creatine phosphate, its preparation and use in pharmaceutical process
CN100493514C (en) * 2005-08-05 2009-06-03 杨喜鸿 Composite medicine of creatine phosphate sodium and magnesium salt

Also Published As

Publication number Publication date
ITTO20050847A1 (en) 2007-06-01
WO2007063509A2 (en) 2007-06-07
WO2007063509A3 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
TW200728307A (en) Novel spirochromanone derivatives
NO20083267L (en) Azaindole inhibitors of aurora kinases
TW200734311A (en) New compounds
WO2006122186A3 (en) 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
IL189694A0 (en) Biphenyl derivatives and their use in treating hepatitis c
WO2008005956A3 (en) Pyrrolotriazine kinase inhibitors
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
MX2009012168A (en) Pyrrolopyridine derivatives and their use as bace inhibitors.
AU2002950217A0 (en) 8- Hydroxy Quinoline Derivatives
WO2009155121A3 (en) Inhibitors of pi3 kinase
WO2008076046A8 (en) Novel 2-amino-5, 5-diaryl-imidazol-4-ones
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
MXPA04004370A (en) Polycyclic guanine derivative phosphodiesterase v inhibitors.
WO2005080352A3 (en) Quinazoline derivatives and therapeutic use thereof
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2006116733A3 (en) Protein kinase inhibitors
WO2003053915A3 (en) Compounds for the treatment of inflammatory disorders
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
WO2006127379A3 (en) Par2-modulating compounds and their use
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06832010

Country of ref document: EP

Kind code of ref document: A2